AE105
AE105 is a 9-mer peptide probe targeting the urokinase-type plasminogen activator receptor (uPAR) . AE105 binds tightly to the uPA-binding cavity of uPAR. AE105 can be used for the study of cancer[1].
Product Specifications
CAS Number
254729-66-3
UNSPSC
12352209
Target
Transmembrane Glycoprotein
Related Pathways
Immunology/Inflammation
Field of Research
Cancer
Purity
96.72
Solubility
DMSO : 50 mg/mL (ultrasonic)
Smiles
OC(C=C1)=CC=C1C[C@H](NC([C@@H](CCCNC(N)=N)NC([C@@H](CO)NC([C@@H](NC([C@@H](NC([C@@H](N)CC(O)=O)=O)CC2CCCCC2)=O)CC3=CC=CC=C3)=O)=O)=O)C(N[C@@H](CC(C)C)C(N[C@H](C(N[C@@H](CO)C(O)=O)=O)CC4=CNC5=CC=CC=C45)=O)=O
Molecular Formula
C60H83N13O15
Molecular Weight
1226.38
References & Citations
[1]Leth JM, et al. Targeted imaging of uPAR expression in vivo with cyclic AE105 variants. Sci Rep. 2023 Oct 11;13 (1) :17248.
Shipping Conditions
Blue Ice
Storage Conditions
-80°C, 2 years; -20°C, 1 year (Powder, sealed storage, away from moisture)
Scientific Category
Peptides
Clinical Information
No Development Reported
Available Sizes
Frequently Asked Questions
More Discoveries
Explore Other Products
Browse additional items from our catalog
